Hyderabad-based Natco Pharma Ltd on Tuesday said it has received the final approval from the US health regulator for its first supplemental abbreviated new drug application (sANDA) filed from its new drug formulations facility at Visakhapatnam, Andhra Pradesh.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VGS6zy
via IFTTT
0 comments:
Post a Comment